Digital support program for people with reduced ejection fraction heart failure

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a cluster-randomized controlled trial testing a tailored digital support program for patients with heart failure with reduced or midrange reduced ejection fraction, alongside a comparison of implementation strategies using RE-AIM, PRISM and ERIC frameworks. The primary outcome is patients' perceived control measured by the Control Attitude Scale, with secondary outcomes including health-related quality of life, self-care behaviors, heart failure knowledge, perceived continuity and participation in care, and depressive symptoms. Eligible participants are adults with an ejection fraction ≤50% verified by echocardiography or MRI, who can use BankID and a smartphone, tablet, or computer and understand Swedish. The trial is led by Linköping University and conducted at Linköping University Hospital with tailored implementation support delivered to participating clinics.

Why it matters

Who can join: the full rules

Inclusion criteria:

* Diagnosed with heart failure with reduced ejection fraction (HFrEF) or heart failure with midrange reduced ejection fraction (HFmrEF) (ejection fraction ≤50%) verified by echocardiography or Magnetic Resonance Imaging
* Access to BankID, a computer, tablet, or smartphone
* Aged ≥18 years
* Able to understand and communicate in Swedish
* Provided informed consent

Exclusion criteria:

* Barriers to participation (e.g., not Swedish-speaking, cognitive impairment, severe mental illness, substance abuse)
* Life expectancy of less than six months

Where it's running

• Linköping University Hospital
  Linköping, Östergötland County, Sweden Recruiting

Study contacts

• Principal investigator: Anna Stroemberg — Linkoeping University
• Study coordinator: Anna Stroemberg, Professor
• Email: anna.stromberg@liu.se
• Phone: +46736569265

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Yoga-based cardiac rehabilitation for heart failure with reduced ejection fraction

  This trial tests whether a yoga-based rehabilitation program can help people with heart failure and reduced ejection fraction compared with an educational program.

  Recruiting at 12 sites Centre for Chronic Disease Control, India · Dharwad, Karnataka and 15 other locations · NCT07817589

• Lumacaftor to improve cerebral blood flow in heart failure with reduced ejection fraction

  This study tests whether lumacaftor can improve brain blood flow and thinking abilities in adults with a certain type of heart failure.

  Recruiting Phase 2 Qanatpharma AG · Toronto, Ontario and 1 other locations · NCT07695090

• Stepwise withdrawal of ARNI and SGLT2i in HF with normalized ejection fraction

  This trial tests whether gradually stopping ARNI and SGLT2i is safe for people whose heart function has recovered after fixing a reversible heart‑disease cause.

  Recruiting Phase 4 Keimyung University Dongsan Medical Center · Daegu, Daegu and 4 other locations · NCT07631156

• Ring-style blood pressure bracelet test compared with 24-hour monitoring in people with HFrEF

  A ring-type blood pressure device is being tested to see if its 24-hour readings match those from standard ambulatory monitoring in adults with heart failure and reduced ejection fraction.

  Recruiting Keimyung University Dongsan Medical Center · Daegu · NCT07626879

• Diet and exercise plan to help people with heart failure and preserved heart function.

  This study tests whether a DASH-style, high-protein diet, resistance exercise, or both can help build muscle and improve fitness and quality of life in people with heart failure and reduced ejection fraction.

  Recruiting Medical University of Silesia · Zabrze, Silesian Voivodeship · NCT07595809

• HFrEF polypill strategy in Sri Lanka

  This study tests whether giving a heart failure polypill can reduce death from heart disease and hospitalizations in adults with HFrEF in Sri Lanka, compared with usual care.

  Recruiting at 10 sites Phase 3 Washington University School of Medicine · Kandy, Central Province and 11 other locations · NCT07569640

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.